Showing 1 - 2 results of 2 for search 'Mark Belger', query time: 0.01s Refine Results
  1. 1
    Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer’s Disease in the United States

    Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer’s Disease in the United States by Malaz Boustani, Erin G. Doty, Louis P. Garrison Jr, Lee J. Smolen, Timothy M. Klein, Daniel R. Murphy, Andrew W. Spargo, Mark Belger, Joseph A. Johnston

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Health economic modeling for Alzheimer's disease: Expert perspectives

    Health economic modeling for Alzheimer's disease: Expert perspectives by Filipa Landeiro, Jasmine Morton, Anders Gustavsson, Michele Potashman, Pascal Lecomte, Mark Belger, Robin Thompson, Emilse Roncancio‐Diaz, Gurleen Jhuti, Christopher Butler, Linus Jönsson, Ron Handels, Alastair M. Gray, the ROADMAP study

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: